One such RNA, SChLAP1, is significantly overexpressed in aggressive prostate cancers and shows promise as a prognostic indicator; this molecule acts to promote metastasis by binding to a tumor-suppressing complex, inhibiting its beneficial properties [12]. Here, SCHLAP1 is linked to neoplasm.